Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.14 M
About ARCH THERAPEUTICS INC
Sector
Industry
CEO
Terrence W. Norchi
Website
Headquarters
Framingham
Founded
2009
ISIN
US03939W2089
FIGI
BBG002PHNCD4
Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ARTHQ is 0.000100 USD — it hasn't changed in the past 24 hours. Watch ARCH THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange ARCH THERAPEUTICS INC stocks are traded under the ticker ARTHQ.
ARTHQ stock hasn't changed in a week, the last month showed zero change in price, over the last year ARCH THERAPEUTICS INC has showed a −99.98% decrease.
ARTHQ reached its all-time high on Jul 11, 2013 with the price of 54,400.000000 USD, and its all-time low was 0.000001 USD and was reached on Apr 30, 2025. View more price dynamics on ARTHQ chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ARTHQ stock is 0.00% volatile and has beta coefficient of 433.62. Track ARCH THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is ARCH THERAPEUTICS INC there?
Yes, you can track ARCH THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
ARCH THERAPEUTICS INC is going to release the next earnings report on Dec 3, 2025. Keep track of upcoming events with our Earnings Calendar.
No, ARTHQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ARTHQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARCH THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARCH THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARCH THERAPEUTICS INC stock shows the sell signal. See more of ARCH THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.